| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |